Renerve Limited has released a press release.
Trading Halt
Filed with ASX ·
On 6ix: 6ix.com/news/trading-halt-1289
6ix hasn’t read this filing yet.
Earlier from Renerve
- Nerve Cuff approved for use in US DoD and VA hospitals
- ReNerve Clinical Study Expansion
- Q1 FY26 Activities Report and Appendix 4C
- ReNerve achieves first sales of amniotic tissue range
- Investor Roadshow Presentation
Later from Renerve
- ReNerve completes $3.2m capital raising
- ReNerve AGM Presentation
- Broader approval received in Hong Kong for Nerve Cuff
- ReNerve receives approval in Malaysia
- Q2 FY26 Activities Report and Appendix 4C
Follow Renerve into a list and get an email when it puts out news.
Follow Renerve